Skip to content
value.today

Tissuetech, Inc.

Total raised
$83 M
5 rounds on record
Latest round
$55 M
Apr 2019
First round on record
Sep 2012
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Tissuetech, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2019$55 MNo. 5$50 to $250 million

Tissuetech, Inc.: Raise no. 5, Apr 2019

Investors in this round

3 investors had bought by the notice of Apr 12, 2019: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$55 M of $82 M offered; $27 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$10,000,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Amy H. Tseng · Executive Officer, Director
  • Devin C.G. Buckley · Executive Officer
  • Michael C.G. Cornelinus · Executive Officer
  • Scheffer C.G. Tseng · Executive Officer, Director
  • Brian C.G. Yeh · Director
  • John C.G. Arnott · Director
  • Martin C.G. Nutter · Director
  • Matt C.G. Rice · Director
  • William C.G. Hawkins · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The company will use a portion of the proceeds (up to the above amount)to offer to repurchase from the company's common stockholders (including certain Related Persons per Item 3), on a pro rata basis, a portion of the shares of common stock held by them.”

Signed by Devin Buckley, Secretary, General Counsel and CCO. Source: SEC Form D, newest notice filed Apr 12, 2019. Read the notice at the SEC.

equitySEC
Jun 2015$15 MNo. 4$10 to $50 million

Tissuetech, Inc.: Raise no. 4, Jun 2015

Investors in this round

7 investors had bought by the notice of Jun 16, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Amy H. Tseng · Executive Officer, Director
  • Devin K. Buckley · Executive Officer
  • Michael K. Cornelius · Executive Officer
  • Scheffer C.G. Tseng · Executive Officer, Director
  • Billy K. Yeh · Director
  • Carter K. Mcnabb · Director
  • Matt K. Rice · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Devin Buckley, Secretary, Corporate Legal Counsel and CCO. Source: SEC Form D, newest notice filed Jun 16, 2015. Read the notice at the SEC.

equitySEC
Sep 2013$1 MNo. 3Under $2 million

Tissuetech, Inc.: Raise no. 3, Sep 2013

Investors in this round

13 investors had bought by the notice of Oct 10, 2013: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
$67,500
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$1,000,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Amy Tseng · Executive Officer, Director
  • Greg Collins · Executive Officer
  • Scheffer Tseng · Executive Officer, Director
  • Billy Yeh · Director
  • Carter McNabb · Director
  • Jane Hsiao · Director
  • Matt Rice · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Greg Collins, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 10, 2013. Read the notice at the SEC.

equitySEC
Aug 2013$10 MNo. 2$10 to $50 million

Tissuetech, Inc.: Raise no. 2, Aug 2013

Investors in this round

3 investors had bought by the notice of Aug 23, 2013: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Amy H. Tseng · Executive Officer, Director
  • Greg K. Collins · Executive Officer
  • Scheffer C.G. Tseng · Executive Officer, Director
  • Billy K. Yeh · Director
  • Carter K. McNabb · Director
  • Jane K. Hsiao · Director
  • Matt K. Rice · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Greg Collins, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 23, 2013. Read the notice at the SEC.

equitySEC
Sep 2012$1 MNo. 1Under $2 million

Tissuetech, Inc.: Raise no. 1, Sep 2012

Investors in this round

8 investors had bought by the notice of Oct 15, 2012: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $7 M offered; $5 M still to sell
Smallest investment taken
$65,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Florida

People named in the notice

  • Amy H. Tseng · Executive Officer, Director
  • Greg K. Collins · Executive Officer
  • Scheffer C.G. Tseng · Executive Officer, Director
  • Billy K. Yeh · Director
  • Jane K. Hsiao · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The offering is closed.”

Signed by Greg Collins, Cfo. Source: SEC Form D, newest notice filed Oct 15, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Tissuetech, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2019).

    SEC Form D · Apr 2019

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2019

That is all the official record says: Tissuetech, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Tissuetech, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Tissuetech, Inc.
NameRoleNamed in
Amy H. TsengExecutive officerApr 2019
Devin C.G. BuckleyExecutive officerApr 2019
Michael C.G. CornelinusExecutive officerApr 2019
Scheffer C.G. TsengExecutive officerApr 2019
Devin K. BuckleyExecutive officerJun 2015
Michael K. CorneliusExecutive officerJun 2015
Amy TsengExecutive officerOct 2013
Greg CollinsExecutive officerOct 2013
Scheffer TsengExecutive officerOct 2013
Greg K. CollinsExecutive officerAug 2013
Amy H. TsengDirectorApr 2019
Brian C.G. YehDirectorApr 2019
John C.G. ArnottDirectorApr 2019
Martin C.G. NutterDirectorApr 2019
Matt C.G. RiceDirectorApr 2019
Scheffer C.G. TsengDirectorApr 2019
William C.G. HawkinsDirectorApr 2019
Billy K. YehDirectorJun 2015
Carter K. McnabbDirectorJun 2015
Matt K. RiceDirectorJun 2015
Amy TsengDirectorOct 2013
Billy YehDirectorOct 2013
Carter McNabbDirectorOct 2013
Jane HsiaoDirectorOct 2013
Matt RiceDirectorOct 2013
Scheffer TsengDirectorOct 2013
Carter K. McNabbDirectorAug 2013
Jane K. HsiaoDirectorAug 2013